Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_assertion type Assertion NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_head.
- NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_assertion description "[These results suggest that efatutazone inhibits cell motility by antagonizing the TGF-?/Smad2 pathway and effectively prevents metastasis in NSCLC patients with acquired resistance to EGFR-TKI regardless of the resistance mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_provenance.
- NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_assertion evidence source_evidence_literature NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_provenance.
- NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_assertion SIO_000772 24698130 NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_provenance.
- NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_assertion wasDerivedFrom befree-2016 NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_provenance.
- NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_assertion wasGeneratedBy ECO_0000203 NP1169930.RAxkZxt41XNUN_oaCk9gunncFZG2RyhpljmrKEfC1IKzM130_provenance.